Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis
about
Several distinct polycomb complexes regulate and co-localize on the INK4a tumor suppressor locusMolecular genetic analysis of Suppressor 2 of zeste identifies key functional domainsBMI-1 promotes ewing sarcoma tumorigenicity independent of CDKN2A repressionBMI1: A Biomarker of Hematologic MalignanciesPolycomb Group (PcG) Proteins and Human Cancers: Multifaceted Functions and Therapeutic ImplicationsZfp423 Regulates Sonic Hedgehog Signaling via Primary Cilium FunctionMultiple recurrent genetic events converge on control of histone lysine methylation in medulloblastomaGFAP-Cre-mediated transgenic activation of Bmi1 results in pituitary tumorsPolycomb group gene BMI1 controls invasion of medulloblastoma cells and inhibits BMP-regulated cell adhesion.Su(z)2 antagonizes auto-repression of Myc in Drosophila, increasing Myc levels and subsequent trans-activationDetection of lower levels of SNAP25 using multiple microarray systems and its functional significance in medulloblastomaBMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer.Polycomb and trithorax opposition in development and disease.Oncogenic role of the chromobox protein CBX7 in gastric cancer.The tandem affinity purification technology: an overview.Identification and characterization of Bmi-1-responding element within the human p16 promoter.RNF2 is the target for phosphorylation by the p38 MAPK and ERK signaling pathways.Expression and clinicopathological significance of Mel-18 and Bmi-1 mRNA in gastric carcinoma.Polycomb genes expression as a predictor of poor clinical outcome in children with medulloblastoma.Validation of Bmi1 as a therapeutic target of hepatocellular carcinoma in mice.Studying clonal dynamics in response to cancer therapy using high-complexity barcoding.The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy.Na,K-ATPase β1-subunit is a target of sonic hedgehog signaling and enhances medulloblastoma tumorigenicity.Bmi-1: At the crossroads of physiological and pathological biology.Triple-layer dissection of the lung adenocarcinoma transcriptome: regulation at the gene, transcript, and exon levelsContextualizing the Genes Altered in Bladder Neoplasms in Pediatric andTeen Patients Allows Identifying Two Main Classes of Biological ProcessesInvolved and New Potential Therapeutic TargetsEwing tumors that do not overexpress BMI-1 are a distinct molecular subclass with variant biology: a report from the Children's Oncology Group.Medulloblastoma stem cells.An Ehrlichia chaffeensis tandem repeat protein interacts with multiple host targets involved in cell signaling, transcriptional regulation, and vesicle traffickingSystems analysis uncovers inflammatory Th/Tc17-driven modules during acute GVHD in monkey and human T cells.Bmi-1, stem cells and cancer.Polycomb group protein gene silencing, non-coding RNA, stem cells, and cancer.Commonly used tag combinations for tandem affinity purification.Genetics of medulloblastoma: clues for novel therapies.Epigenetic factors in cancer development: polycomb group proteins.The proteomics of cancer stem cells: potential clinical applications for innovative research in oncology.Cancer stem cell epigenetics and chemoresistance.Tumor suppressive pathways in the control of neurogenesis.Roles of repressive epigenetic machinery in lineage decision of T cells.Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
P2860
Q24317899-4EEF3142-1815-412D-8407-D4F2B8E89ED7Q24649818-5232A738-FA35-4EF1-BA8C-4604CAF873CCQ24650619-3338A6B5-63A3-445F-A811-410A69D2CDECQ26750676-BECA4206-707A-4544-A002-8A412882BDFDQ26801380-CA218833-0B9E-46F2-9CA5-FB08634D0AD1Q27307807-A93789A0-5EF6-4CE6-9B99-7D8732738DC4Q28237604-C3358D13-5EB0-4FAB-9274-D8A5A4D43E94Q28730123-10E58196-275C-40C3-B939-5A132493DFB1Q30572259-3977CA46-7E9F-4077-97BB-AAB8BDFE2D78Q33424513-64409021-5FB7-45B1-97BC-B9DDC288DFAFQ33598847-DCBBC69A-5317-4E43-BD3A-D09741CEE8A7Q33741646-EA8E85C3-76A3-45F6-8209-A3F955A5708AQ33920032-FD06BF2A-B47B-4539-8DB2-D4848587CC90Q34105084-A5632B19-1D0D-4EFB-AAAD-28B8397B24FAQ34172439-D8BCBF16-AF29-45B2-AB4F-6D1E01CBD004Q34236567-9E86B2BC-59DD-4AC4-B3E1-31F938289BF9Q34356314-D84752C4-B353-47F6-8F80-527073849DF1Q34360544-E713DBCB-159E-4608-8884-D63D1D2EDAB9Q34462864-4880CEDA-D979-4BE5-B301-F514D59544A9Q34685225-FCB264EB-0013-4BB1-9FD6-BFB1922162F6Q35596310-4D96D5AD-3DC9-4413-9386-B897943B2235Q35872419-1085C8B4-D6EE-4C99-B73B-A32009520CCCQ35982129-FFDC09DF-8AD9-4154-A723-17FA10F449A6Q36121000-BEE8004D-1CDF-4A66-841A-FDB918EA6864Q36557126-768F89C1-B4DD-41FA-B34B-8247FF35776BQ36658489-2C64AF46-BBBF-4207-9C86-06A4450F2B23Q37012862-002FAEBF-C2B1-4A16-A3CB-C60DACA79B9FQ37186416-4D3994C7-2DA8-41BF-95B6-F5B75116AF19Q37191245-A7B0A82A-85A8-48A5-897A-4F8DD4AF7D18Q37439966-F89CB837-4231-4FEA-B341-39390A0160EEQ37541792-3ED099DD-A81D-4C26-AAFF-2070BE491C6AQ37629613-20EEB0FD-8EFB-4947-A03E-14A3A9D3EF88Q37692517-CDB71674-1274-4FC8-B1A7-37223220A70AQ37737307-A34A28B3-7F5F-4664-8C80-546EB2A70F8BQ37822735-7B58D369-8EBF-4E6C-917B-10068DCB6E1AQ37940376-2BAD8E43-6FD2-442E-88B4-049DB2E8F257Q37961977-18D75656-466A-4B7A-96F6-C7695A87F8C1Q38026794-3932C7CE-A5AD-455D-8FA3-81BA22093235Q38070800-E541BBE2-B72C-477B-A1A8-E6518C40F215Q38826126-4A8FC1B6-A3D1-4547-8EFB-B8DFD19143D1
P2860
Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis
@ast
Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis
@en
Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis
@nl
type
label
Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis
@ast
Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis
@en
Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis
@nl
prefLabel
Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis
@ast
Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis
@en
Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis
@nl
P2093
P2860
P921
P3181
P356
P1476
Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis
@en
P2093
Brett Johnson
Dmitri Wiederschain
Dowdy Jackson
James Deeds
John D Benson
John Taraszka
Kimberly Bettano
Michael D Jones
Michael Morrissey
P2860
P304
P3181
P356
10.1128/MCB.02244-06
P407
P577
2007-07-01T00:00:00Z